1. Manini I, Montomoli E. Epidemiology and prevention of Human Papillomavirus. Annali diigiene: medicina preventiva e di comunita. 2018;30(Supple 1):28–32.
2. National Cancer Institute at the National Institutes of Health. Human Papillomavirus (HPV) Vaccines. National Institutes of Health 2021a; https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#r5.
3. National Cancer Institute at the National Institutes of Health. HPV and Cancer. National Institutes of Health 2021b; https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer.
4. McQuillan G, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R. Prevalence of HPV in adults aged 18–69: United States, 2011–2014. NCHS Data Brief. 2017;280:1–8.
5. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. U.S. Cancer Statistics Data Visualizations Tool, based on 2020 submission data (1999–2019). Centers for Disease Control and Prevention 2022; https://gis.cdc.gov/Cancer/USCS/#/Demographics/